1178: ANTI-FACTOR XA MONITORING OF HEPARIN FOR THE TREATMENT OF PULMONARY EMBOLISM MANAGED BY A PERT TEAMdoi:10.1097/01.ccm.0001002876.29493.e1Eric ZhuBeth Israel Deaconess Medical CenterEugene YuriditskyNYU Langone HealthVeronica RacoNYU Langone BrooklynAlyson Katz...
Antifactor Xa Assay Heparin Antifactor Xa AssayHeparin Antifactor Xa AssayTime, Activated ClottingPartial, ActivatedTime, ThromboplastinNeutralization, HeparinTime, ThrombinAntifactor, SynonymsAssay, XaAssay, AntixaAssay, Heparin
Factor Xa inhibitors (i.e., apixaban, rivaroxaban) No effect on pharmacokinetics of coagulation factor Xa (recombinant), inactivated-zhzo Heparin May interfere with the anticoagulant effect of heparin Avoid use of coagulation factor Xa (recombinant), inactivated-zhzo prior to heparinization; use...
Heparin-dependent inactivation of admixed factor Xa is quantified. Before addition of factor Xa, the sample is incubated with a heparin-modifying component. The sample may be incubated with an enzyme from the group of heparinases or with an enzyme from the group of glucuronidases or with a ...
Outcomes of Clinical Nurse Specialist Practice in the Implementation of Video Monitoring at an Academic Medical Center Purpose/Objectives: The purpose of this project was to design and implement a program that utilizes video cameras with the goal of monitoring for and preve... Purvis,Suzanne,Kaun,...
For this heparin a more effective anti-Xa-activity was measured (p < 0.05). In vitro no differences of the heparins were registered on the test systems in a range of 0.01-2.0 USP/ml plasma. The data indicate, that heparin preparations with the same MW and the same in vitro activities ...
Anti-factor Xa Microdialysis Microfluidic Real-time monitoring Therapeutic drug monitoring Abbreviations UFH unfractionated heparin LMWH low molecular weight heparin 1. Introduction Vascular thrombosis can occur in both arterial and venous circulation and is the leading cause of cardiovascular morbidity and mor...
The effect of heparin fractions of various Mr, with high affinity for antithrombin III, on the kinetics of the reaction between factor Xa and antithrombin III have been studied using purified human proteins. Each of the heparin fractions, which varied between pentasaccharide and Mr 32,000, accele...
A direct evaluation of the specific anti-factor Xa (fXa) activity of therapeutic heparins in the physiologically relevant plasma-based clotting assays has not been feasible since thrombin, the final protease of the cascade, is the primary target for inhibition by AT in the presence of heparin. ...
Dose adjustment or laboratory monitoring of low-molecular-weight heparin (LMWH) is commonly recommended for patients with severe renal insufficiency (creat... Lim,Wendy - 《Annals of Internal Medicine》 被引量: 973发表: 2006年 Influence of patient characteristics and renal function on factor Xa inh...